Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease

Diabetic Medicine

Volumn 23, Issue 4, 2006, Pages 436-440

  Rooney, D P ^a   Ryan, M F ^a  

^a ANTRIM AREA HOSPITAL   (United Kingdom)

Author keywords

Adiponectin; Diabetes; Graft vs. host disease; Lipodystrophy; Pioglitazone

Indexed keywords

ADIPONECTIN; INSULIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BUTTOCK; CASE REPORT; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DISEASE ASSOCIATION; FACE; FEMALE; FOREARM; HOST; HUMAN; INSULIN RESISTANCE; LEG; LIPODYSTROPHY; NECK; PATHOGENESIS; POSTOPERATIVE COMPLICATION; SCAR; SCLERODERMA; SERUM; THIGH; THORAX;

ADOLESCENT; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, TYPE 2; FEMALE; GRAFT VS HOST DISEASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LIPODYSTROPHY; METFORMIN; SCLERODERMA, LOCALIZED; TRANSPLANTATION, HOMOLOGOUS;

EID: 33645376969     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01855.x     Document Type: Article

References (15)

1. Taskinen M Saarinen-Pihkala UM Hovi L Lipsanen-Nyman M. Impaired glucose intolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000 356 993 997.
2. Amin P Shah S Walker D Page SR. Adverse metabolic and cardiovascular risk following treatment of acute lymphoblastic leukaemia in childhood; two case reports and a literature review. Diabet Med 2001 18 849 853.
3. Garg A. Medical progress: acquired and inherited lipodystrophies. N Engl J Med 2004 350 1220 1234.
4. Chen D Misra A Garg A. Lipodystrophy in human immunodeficiency virus infected patients. J Clin Endocrinol Metab 2002 87 4845 4856.
5. Chosidow O Bagot M Vernant JP Roujeau JC Cordonnier C Kuentz M et al. Sclerodermatous chronic graft-versus-host-disease. Analysis of seven cases. J Am Acad Dermatol 1992 26 49 55.
6. Shackleton S Lloyd DJ Jackson SN Evans R Niermeijer MF Singh BM et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 2000 24 153 156.
7. Vogelsang GB. Chronic graft versus host disease. B J Haematol 2004 125 435 454.
8. Carr A Workman C Carey D Rogers G Martin A Baker D et al. No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomized, double-blind, placebo-controlled trial. Lancet 2004 363 429 438.
9. Haque WA Shimomura I Matsuzawa Y Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002 87 2395 2398.
10. Yokota T Oritani K Takahashi I Ishikawa J Matsuyama A Ouchi N et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages. Blood 2000 96 1723 1732.
11. Yamauchi T Kamon J Waki H Terauchi Y Kubota N Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001 7 941 946.
12. Yu JG Javorschi S Hevener AL Krasynska YT Normon RA Sinha M et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002 51 2968 2974.
13. Owen KR Donohoe M Ellard S Hattersley AT. Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene. Diabet Med 2003 20 823 827.
14. Bastard JP Caron M Vidal H Jan V Auclair M Vigoureux C et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002 359 1026 1031.
15. Vigouroux V Gharakhanian S Salhi Y Nguyen TH Chevenne D Capeau J et al. Diabetes, insulin resistance and dyslipidemia in lipodystrophic, HIV-infected patients on highly active antiretroviral therapy (HAART). Diab Metab 1999 25 225 232.